Short answer
SOLESENCE, INC. (SLSN) filed its Q1 2026 10-Q quarterly report on May 12, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $13M (down 11.4% year over year) with net income of −$766,000.
Q1 2026 key financials · XBRL
- Revenue
- $13M
- −11.4% YoY
- Net income
- −$766,000
- −1057.5% YoY
- Operating margin
- -3.9%
- Gross margin
- 25.8%
- EPS (diluted)
- −$0.01
Source: XBRL data from the SOLESENCE, INC. (SLSN) Q1 2026 10-Q on SEC EDGAR. USD.
SOLESENCE, INC. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $12,957, down $1,668 from $14,625 YoY
- Cost of revenue $9,620 vs $11,243; gross margin 25.7% vs 23.1% YoY
- Personal Care Ingredients best-performing category; higher sales offset lower Consumer Products and Advanced Materials sales
- Cash $573 vs $1,817; operating cash flow $1,517 vs $(7,221) YoY
- 2026 capital spending expected between $0.5 million and $1.5 million; inflation and tariffs may pressure margins
Risk Factors
- Risk Factors: Not required for smaller reporting company
- No newly added or updated risk factors provided in the filing excerpt
- Regulatory and compliance detail limited to executive certifications under Exchange Act Rules 13a-14(a) and 15d-14(a)
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SOLESENCE, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.